Activist 13D/13G Filings - Erytech Pharma S.A.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportFiling
2023-02-14
12:41 pm
Sale		13GPHAXIAM THERAPEUTICS S.A. AMER
PHXM		ARMISTICE CAPITAL LLC1,629,118
4.99%		-1,108,134decrease
(-40.48%)		View
2023-02-13
6:08 pm
Sale		13GPHAXIAM THERAPEUTICS S.A. AMER
PHXM		BIOTECHNOLOGY VALUE FUND L P517,242
1.6%		-1,782,059decrease
(-77.50%)		View
2022-12-23
5:08 pm
Sale		13GPHAXIAM THERAPEUTICS S.A. AMER
PHXM		BIOTECHNOLOGY VALUE FUND L P2,299,301
7.4%		-2,819,882decrease
(-55.08%)		View
2022-02-14
6:28 pm
Purchase		13GPHAXIAM THERAPEUTICS S.A. AMER
PHXM		ARMISTICE CAPITAL LLC2,737,252
9.3%		2,737,252increase
(New Position)		View
2022-02-14
1:49 pm
Purchase		13GPHAXIAM THERAPEUTICS S.A. AMER
PHXM		BIOTECHNOLOGY VALUE FUND L P5,119,183
16.5%		1,037,242increase
(+25.41%)		View
2021-03-09
9:40 pm
Unchanged		13GPHAXIAM THERAPEUTICS S.A. AMER
PHXM		BIOTECHNOLOGY VALUE FUND L P4,081,941
19.3%		0
(Unchanged)		View
2021-01-29
4:36 pm
Sale		13DPHAXIAM THERAPEUTICS S.A. AMER
PHXM		BIOTECHNOLOGY VALUE FUND L P4,081,941
20.4%		-380,000decrease
(-8.52%)		View
2021-01-12
5:10 pm
Unchanged		13DPHAXIAM THERAPEUTICS S.A. AMER
PHXM		BIOTECHNOLOGY VALUE FUND L P4,461,941
22.3%		0
(Unchanged)		View
2020-10-13
5:18 pm
Sale		13DPHAXIAM THERAPEUTICS S.A. AMER
PHXM		BIOTECHNOLOGY VALUE FUND L P4,461,941
23.5%		-85,721decrease
(-1.88%)		View